Friedman Franklin Stuart 4
4 · Deciphera Pharmaceuticals, Inc. · Filed Jun 23, 2023
Insider Transaction Report
Form 4
Friedman Franklin Stuart
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-06-21+30,000→ 30,000 totalExercise: $14.91Exp: 2033-06-20→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]This stock option was issued pursuant to the Issuer's 2017 Stock Option and Incentive Plan. The option shall vest in full on June 21, 2024, subject to continued service through such date.